If a MOA is intended to activate the innate immune system combined with one that activates the adaptive immune system wouldn't (theoretically) that also be a sign the drugs are functioning according to their intended effect? NKTR claims 262 was designed to be combined with 214 and from the posters of their single agent vs. combined activity looks HIGHLY synergistic.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.